Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 15, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 July 2026 - 15:11

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 15, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/scemblix

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters